Literature DB >> 10585282

Up-regulation of type XIX collagen in rhabdomyosarcoma cells accompanies myogenic differentiation.

J C Myers1, D Li, N A Rubinstein, C C Clark.   

Abstract

Rhabdomyosarcomas are known to recapitulate some of the early events in skeletal muscle embryogenesis, and cultures derived from these tumors have been extensively used to elucidate processes associated with the differentiation of primitive mesenchymal cells. These neoplasms have also provided important systems for studying different collagen types. This aspect is particularly relevant to type XIX collagen, which was originally identified from rhabdomyosarcoma cDNA clones. Although this collagen has been localized in vivo to basement membrane zones in a wide variety of tissues, including skeletal muscle, the tumor cells appear to be a unique source of its expression in vitro. We have found that one particular cell line-derived from a peritesticular embryonal rhabdomyosarcoma-produced relatively large amounts of type XIX collagen, especially in those rare instances in which these cells appear to spontaneously differentiate. To characterize this phenomenon, tumor cells were grown under conditions known to induce differentiation in normal myoblast cultures. In response to this treatment, the typical tumor cell morphology consistently and reproducibly switched from polygonal to round/spindle-shaped with the subsequent appearance of some structures resembling myotubes. Concurrently, the cultures commenced a dramatic up-regulation of type XIX collagen and skeletal muscle myosin heavy chain and alpha-actinin in a time-dependent fashion, whereas protein and mRNA levels of other matrix proteins were either decreased or unchanged. Moreover, immunocytochemical analysis revealed that only a subpopulation of the cells was responsible for the increased synthesis of type XIX collagen, alpha-actinin, and myosin, and that the same cells which stained positive for the collagen also stained positive for the muscle proteins. Taken together, the results suggested that type XIX collagen may be involved in the initial stages of skeletal muscle cell differentiation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585282     DOI: 10.1006/excr.1999.4642

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  5 in total

1.  Mechanics and multiple-particle tracking microheterogeneity of alpha-actinin-cross-linked actin filament networks.

Authors:  Y Tseng; D Wirtz
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

Review 2.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

3.  Abnormalities in esophageal smooth muscle induced by mutations in collagen XIX.

Authors:  Haruna Sato; Kyoko Jin; Shinji Yano; Aiko Yasuda; Sawako Adachi; Hidekatsu Yoshioka; Hirokazu Kitamura; Takako Sasaki
Journal:  Histochem Cell Biol       Date:  2022-01-07       Impact factor: 4.304

4.  The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction.

Authors:  Jean-Baptiste Oudart; Manon Doué; Alexia Vautrin; Bertrand Brassart; Christèle Sellier; Aurelie Dupont-Deshorgue; Jean-Claude Monboisse; François-Xavier Maquart; Sylvie Brassart-Pasco; Laurent Ramont
Journal:  Oncotarget       Date:  2016-01-12

Review 5.  Type XIX collagen: a promising biomarker from the basement membranes.

Authors:  Ana C Calvo; Laura Moreno; Leticia Moreno; Janne M Toivonen; Raquel Manzano; Nora Molina; Miriam de la Torre; Tresa López; Francisco J Miana-Mena; María J Muñoz; Pilar Zaragoza; Pilar Larrodé; Alberto García-Redondo; Rosario Osta
Journal:  Neural Regen Res       Date:  2020-06       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.